09/18/2025                                                                            
                                    
                                                                            
                                            Joseph Zucchi's new Op-Med was published today on Doximity: GLP-1 medications keep proving their value, but obesity medication coverage is moving backward.
These therapies lower cardiovascular risk, improve sleep apnea, and help patients achieve meaningful health gains, yet insurers and PBMs are rolling out blanket exclusions at the very moment the science is strongest.
In the piece, he talk about this widening gap between evidence and access, why it is so frustrating for patients and clinicians, and why the conversation around affordability needs to include more thoughtful solutions than simply cutting coverage.
Coverage cuts may look like short-term savings, but they translate into long-term costs and preventable suffering. We need to keep advocating for patient access and bringing visibility to these decisions. Please read, share, and add your voice to this conversation.
Link: https://www.doximity.com/articles/d09921a2-eaa1-49dd-bca1-1a582f28edef